
Episode #14
The Nupsala Podcast Episode 14 | From Equine to Canine: The Case for iPAAG as a Game-Changer in Osteoarthritis Management
Recorded live at VOACON, this episode brings together two leading voices in musculoskeletal veterinary medicine. Dr. Jason Lowe, Chief Veterinary Officer at Contura Vet, and Dr. Alex Keller, specialist in ultrasonography and canine rehabilitation, sit down to explore the growing role of 2.5% polyacrylamide hydrogel (iPAAG) in the management of canine osteoarthritis. Drawing on decades of experience across equine and small animal medicine, Jason and Alex discuss why iPAAG is increasingly being recognised as a mechano-modulating synovial implant rather than a conventional drug, and what that distinction means for how vets should be thinking about it. They cover everything from early diagnosis and case selection, to dosing, longevity of effect, and how to have the conversation with clients. The episode also tackles some of the biggest barriers to adoption, including fear of intra-articular injections, the lack of canine-specific research to date, and the myths surrounding the product's safety profile. With data now emerging from studies in Australia, the US and beyond, both speakers make a compelling case for why now is the time for general practitioners to get comfortable with this approach.






